SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
EVERTEC issued a press release on August 4, 2026 announcing preliminary Q2 2026 results with revenue of $274.8 million (20% growth), GAAP net income of $5.4 million ($0.09 per diluted share), and Adjusted EBITDA of $109.3 million (18% growth), along with raised full-year 2026 guidance.
View raw filing on EDGAR →The Board approved on July 31, 2026 an increase to the share repurchase authorization by $150 million, expanding the total new authorization while maintaining the December 31, 2027 expiration date.
View raw filing on EDGAR →Compass issued a press release on August 4, 2026 announcing financial results for Q2 2026 ended June 30, 2026, disclosing revenue of $4.31 billion (14% YoY growth on pro forma basis), GAAP net income of $92 million, and Adjusted EBITDA of $363 million. The filing explicitly states this is an earnings announcement with forward guidance for Q3 and full-year 2026, furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →This is a straightforward earnings release disclosing Intapp's financial results for its fourth quarter and fiscal year ended June 30, 2026. The press release (Exhibit 99.1) provides comprehensive quarterly and annual financial highlights including SaaS revenue ($115.0M in Q4, up 27% YoY), Cloud ARR ($495.7M, up 29% YoY), GAAP and non-GAAP operating and net income metrics, and forward guidance for fiscal 2027. This is a material disclosure affecting investor assessment of the company's financial performance and outlook.
View raw filing on EDGAR →Evolus entered into a material amendment to its License, Supply and Distribution Agreement with Symatese on August 3, 2026, expanding exclusive commercialization rights for Estyme® to Canada, Australia, and New Zealand. The amendment includes €920,000 in upfront payments plus up to €1.38 million in regulatory milestone payments over a 15-year initial term per territory, representing a strategic expansion into markets with approximately $500 million in total addressable market.
View raw filing on EDGAR →Flywire disclosed preliminary and unaudited financial results for Q2 2026 (quarter ended June 30, 2026), reporting revenue of $167.7 million (up 27.2% YoY) and adjusted EBITDA of $24.0 million (up 44.5% YoY), along with raised full-year guidance for FX-Neutral Revenue Less Ancillary Services growth and Adjusted EBITDA margin growth. The disclosure was made via press release and investor presentation furnished on August 4, 2026.
View raw filing on EDGAR →LGI Homes issued a press release on August 4, 2026 announcing financial results for the second quarter and six months ended June 30, 2026, including homebuilding revenues of $501.5 million and $821.2 million respectively, net income of $27.0 million ($1.16 EPS), 1,440 home closings, and updated full-year 2026 guidance for home closings, average sales price, and gross margins.
View raw filing on EDGAR →ONE Gas announced second quarter 2026 financial results on August 4, 2026, reporting adjusted net income of $52.1 million ($0.82 per diluted share) and raising full-year 2026 adjusted earnings guidance to the upper half of previously announced ranges ($306–$314 million net income; $4.83–$4.95 per share).
View raw filing on EDGAR →PROCEPT BioRobotics issued a press release on August 4, 2026 announcing unaudited financial results for the quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($94.5 million, up 19% YoY), gross margin (66%), net loss ($26.9 million), and full-year 2026 guidance (revenue $390–$410 million, representing 27–33% growth). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →This is a press release announcing Paylocity's fourth quarter and fiscal 2026 financial results for the period ended June 30, 2026, filed on August 4, 2026 under Item 2.02. The disclosure includes detailed quarterly and full-year revenue, operating income, net income, EBITDA, and cash flow metrics, along with forward-looking guidance for Q1 and fiscal 2027. This is a standard earnings release that would materially affect a reasonable investor's assessment of the company's financial performance and outlook.
View raw filing on EDGAR →Arista Networks issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing revenue of $3.036 billion (up 37.7% year-over-year), GAAP diluted EPS of $0.95 (up from $0.70), and non-GAAP diluted EPS of $1.02 (up from $0.73). The filing explicitly states this is furnished under Item 2.02 "Results of Operations and Financial Condition" with full financial statements, income statement, balance sheet, and cash flow statement included. This is a standard quarterly earnings release with material financial results.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (quarter ended June 27, 2026) issued on August 4, 2026. The Item 2.02 disclosure explicitly states "Rayonier Advanced Materials Inc. issued a press release announcing financial results for the quarter ended June 27, 2026" with the press release furnished as Exhibit 99.1. The exhibit contains detailed quarterly financial results including net sales ($376 million, up 11% YoY), operating loss, adjusted EBITDA, and segment performance metrics—all hallmarks of a standard earnings release.
View raw filing on EDGAR →Westlake Chemical Partners LP issued a press release on August 4, 2026 announcing its second quarter 2026 financial results, including net income of $14.2 million ($0.40 per unit), cash flows from operating activities of $129.8 million, and MLP distributable cash flow of $17.6 million.
View raw filing on EDGAR →Wayfair issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 net revenue of $3.5 billion (up 7.5% YoY), net loss of $1 million, and free cash flow of $301 million. This is a standard quarterly earnings release with detailed financial statements and operating metrics, clearly falling under Item 2.02 Results of Operations and Financial Condition.
View raw filing on EDGAR →The Chemours Company issued a press release on August 4, 2026, disclosing its second quarter 2026 financial results, including net sales of $1.6 billion, net loss of $274 million ($1.81 per diluted share), and adjusted EBITDA of $247 million. The filing explicitly states "The Chemours Company Reports Second Quarter Results" and provides comprehensive quarterly financial metrics, segment performance, and forward guidance—the hallmark of an earnings release under Item 2.02.
View raw filing on EDGAR →This is a clear earnings release disclosing Ingredion's second quarter 2026 financial results, including reported and adjusted operating income, diluted EPS ($1.78 reported, $2.82 adjusted), segment performance, and full-year guidance. The press release is furnished as Exhibit 99 and Item 2.02 explicitly states the Company issued a press release announcing condensed consolidated financial results for the quarter ended June 30, 2026.
View raw filing on EDGAR →This is a press release announcing Wix's second quarter 2026 financial results, including Q2 bookings of $569 million (up 12% y/y), revenue of $563 million (up 15% y/y), and detailed segment performance metrics. The document explicitly states "Wix Reports Second Quarter 2026 Results" and provides comprehensive financial disclosures including GAAP and non-GAAP metrics, guidance for Q3 and full-year 2026, and operational highlights such as the launch of Base44's proprietary LLM (Base 1). This is a material earnings disclosure that would affect a reasonable investor's assessment of the company's financial performance and outlook.
View raw filing on EDGAR →InfuSystem issued a press release on August 4, 2026 reporting financial results for the second quarter ended June 30, 2026, disclosing net revenues of $36.9 million (2.6% increase YoY), net income of $3.2 million ($0.15 per diluted share), and Adjusted EBITDA of $8.6 million with 23.4% margin. The press release is furnished as Exhibit 99.1 to the 8-K under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. This is a material disclosure affecting investor assessment of the company's operational and financial performance.
View raw filing on EDGAR →This is a clear earnings release disclosing Kimberly-Clark's second quarter and first half 2026 financial results. The Item 2.02 section explicitly states that a press release dated August 4, 2026 reporting "the Corporation's results of operations for the quarter ended June 30, 2026" is attached as Exhibit 99.1. The exhibit contains detailed quarterly and year-to-date financial metrics including net sales, gross margin, operating profit, and diluted EPS, along with segment results and forward guidance—all hallmarks of a material earnings disclosure.
View raw filing on EDGAR →Brightstar Lottery PLC disclosed its second quarter 2026 financial results, reporting revenue of $584 million, income from continuing operations of $56 million, and Adjusted EBITDA of $286 million, along with reaffirmed full-year 2026 guidance.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) filed under Item 2.02 of Form 8-K. The press release discloses consolidated sales of $194.9 million (up 7.7%), diluted EPS of $0.32 (up from $0.16), gross profit margins of 61.4%, and comparable store sales growth of 8.0%, along with detailed financial statements and forward guidance. The filing explicitly states the press release is "furnished as Exhibit 99.1 and incorporated by reference herein" pursuant to Item 2.02.
View raw filing on EDGAR →This is a press release announcing SOPHiA GENETICS' second quarter 2026 financial results, including revenue of $23.3 million (up 27% YoY), net loss of $22.4 million, and adjusted EBITDA loss of $8.8 million. The release includes detailed financial highlights, business metrics, and updated full-year 2026 revenue guidance ($94–$96 million, raised from prior range of $92–$94 million). The exhibit contains interim condensed consolidated financial statements for the three and six months ended June 30, 2026, confirming this is a discrete earnings announcement, not a periodic financial report.
View raw filing on EDGAR →During Q2 2026, Wheels Up closed on multiple debt transactions: a new $100 million term loan from its lead investor group, a new $68 million aircraft financing facility arranged by AIP Capital, and an extension of Delta's $100 million revolving credit facility commitment by two additional years to September 20, 2028. These transactions represent material creation of direct financial obligations totaling at least $168 million in new debt facilities.
View raw filing on EDGAR →Wheels Up disclosed financial results for the second quarter ended June 30, 2026, including GAAP revenue of $182.0 million, net loss of $107 million, and key operating metrics presented in a press release and investor letter with detailed financial tables and CEO commentary.
View raw filing on EDGAR →Better Home & Finance Holding Co disclosed preliminary Q2 2026 financial results via press release on August 3, 2026, reporting Funded Loan Volume of $1.67B, Revenue of $54.7M, Net Loss of $30.6M, and Adjusted EBITDA of -$14.0M.
View raw filing on EDGAR →Daniel Lewis was appointed as Interim Chief Executive Officer effective immediately on August 3, 2026, following Founder Vishal Garg's mutual agreement to transition from the CEO role, representing a significant change in the company's leadership.
View raw filing on EDGAR →DigitalOcean issued a press release on August 4, 2026 announcing financial results for Q2 2026 (quarter ended June 30, 2026), disclosing revenue of $281 million (up 29% YoY), ARR of $1,125 million, net income of $35 million, and raising full-year 2026 revenue guidance to 30-31% growth. This is a standard quarterly earnings release filed under Item 2.02, materially affecting investor assessment of the company's financial performance and outlook.
View raw filing on EDGAR →BellRing Brands disclosed quarterly financial results for Q3 fiscal 2026 (ended June 30, 2026) via press release on August 4, 2026, including net sales of $570.4 million, operating profit of $65.4 million, net earnings of $34.2 million, and updated full-year 2026 guidance. The filing is filed under Item 2.02 (Results of Operation and Financial Condition) with the earnings press release attached as Exhibit 99.1, which is the standard disclosure mechanism for quarterly earnings releases.
View raw filing on EDGAR →Arvinas disclosed its financial results for Q2 2026 (quarter ended June 30, 2026) via press release furnished as Exhibit 99.1. The disclosure includes detailed financial metrics (cash position of $567.9 million, R&D expenses of $52.6 million, revenue of $249.7 million), operational highlights (FDA approval of VEPPANU, licensing to Rigel Pharmaceuticals), and pipeline updates. This is a standard quarterly earnings release material to investors assessing the company's financial condition and progress.
View raw filing on EDGAR →Katapult issued a press release on August 4, 2026 disclosing financial results for the three and six months ended June 30, 2026, including gross originations, revenue, operating expenses, net loss, adjusted EBITDA, and cash position. The press release is furnished as Exhibit 99.1 and explicitly discloses quarterly financial results, which is the hallmark of an earnings release under Item 2.02.
View raw filing on EDGAR →Enpro Inc. issued a press release on August 4, 2026, announcing its financial results for the quarter ended June 30, 2026, including sales of $338.8 million (up 17.6%), net income of $27.1 million, diluted EPS of $1.27, and adjusted EBITDA of $86.9 million. The company also raised full-year 2026 guidance for revenue growth, adjusted EBITDA, and adjusted diluted EPS. This is a standard quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →AdaptHealth issued a press release on August 4, 2026, announcing financial results for the quarter ended June 30, 2026, disclosing Q2 net revenue of $740.3 million (up 12.7%), organic revenue growth of 15.9%, and a net loss of $145.3 million (largely due to a $144.2 million goodwill write-down). The filing also includes revised full-year 2026 guidance for net revenue, Adjusted EBITDA, and free cash flow. This is a standard quarterly earnings disclosure furnished under Item 2.02.
View raw filing on EDGAR →Camp4 Therapeutics completed the second closing of a private placement on August 3, 2026, issuing 10,756,498 shares at $1.53 per share, 39,306 insider shares at $1.65 per share, and 21,925,368 pre-funded warrants at $1.5299 per warrant, generating approximately $50.1 million in gross proceeds. The securities were sold under Section 4(a)(2) exemption without registration under the Securities Act of 1933, resulting in material dilution to existing shareholders.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 ended June 30, 2026, filed under Item 2.02 "Results of Operations and Financial Condition." The press release discloses comprehensive GAAP and non-GAAP financial results including revenue of $72.5 million (60.7% YoY growth), net loss from continuing operations of $(10.5) million, Adjusted EBITDA of $7.9 million, and updated 2026 full-year guidance. The filing explicitly states the press release is "furnished as Exhibit 99.1" and is "incorporated by reference herein," which is the standard format for earnings releases on Form 8-K.
View raw filing on EDGAR →Angel Oak Mortgage REIT issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, including GAAP net income of $3.4 million ($0.14 per diluted share), net interest income of $10.7 million, and book value metrics. The filing explicitly states in Item 2.02 that the Company "issued a press release announcing its financial results for the quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →The filing discloses Albany International's issuance of a news release reporting second-quarter 2026 financial results, with the release furnished as Exhibit 99.1. This is a classic earnings release disclosure under Item 2.02, which would materially affect a reasonable investor's assessment of the company's financial performance and condition.
View raw filing on EDGAR →Zebra Technologies announced its second quarter 2026 financial results on August 4, 2026, disclosing net sales of $1,557 million (20.4% YoY growth), net income of $233 million ($4.85 per diluted share), and raising its full-year 2026 outlook. The press release attached as Exhibit 99.1 is the standard earnings announcement format with detailed financial highlights, segment performance, balance sheet data, and forward guidance. This is a quintessential Item 2.02 earnings release disclosure.
View raw filing on EDGAR →The filing discloses Global Business Travel Group's Q2 2026 financial results via a press release attached as Exhibit 99.1. The Item 2.02 disclosure explicitly states "the Company issued a press release announcing the Company's financial results for the quarter ended June 30, 2026," with detailed consolidated statements of operations, balance sheets, and cash flows showing 38% revenue growth, $870 million in quarterly revenue, and $17 million net income. This is a standard quarterly earnings release material to investors.
View raw filing on EDGAR →Rhythm Pharmaceuticals announced its second quarter 2026 financial results on August 4, 2026, reporting net product revenue of $71.3 million, a net loss of $(50.4) million, and providing full-year 2026 financial guidance. The earnings release also included preliminary Phase 2 data for RM-718 in acquired hypothalamic obesity showing an 11.6% mean BMI reduction at 16 weeks.
View raw filing on EDGAR →Central Bancompany issued a press release on August 4, 2026 announcing second quarter 2026 financial results, disclosing net income of $113.8 million ($0.47 per diluted share), net interest income of $212.8 million, and a 2.24% return on average assets.
View raw filing on EDGAR →Central Bancompany declared a regular quarterly cash dividend of $0.12 per share payable on September 1, 2026, and approved a new $100 million stock repurchase program.
View raw filing on EDGAR →Baxter announced cash tender offers to repurchase up to $500 million in aggregate principal amount of outstanding senior notes across four series (due 2051, 2046, 2043, and 2032). While this is technically a debt repurchase rather than new debt issuance, it represents a material capital structure transaction that creates or modifies direct financial obligations. The $500 million cap, multiple series involved, and detailed terms (early tender premiums, acceptance priority levels, settlement dates) indicate a significant financial event affecting the company's debt portfolio and liquidity position.
View raw filing on EDGAR →Griffon completed the sale of its AMES Australasia business on July 31, 2026, to a joint venture in which it retains a 49% equity interest. The company received $181 million in cash and a $49 million PIK note, materially affecting its asset base and operating structure.
View raw filing on EDGAR →Knife River Corporation issued a press release on August 4, 2026 announcing second quarter 2026 earnings results, disclosing revenue of $938.6 million (13% YoY growth), net income of $43.9 million, adjusted EBITDA of $139.7 million, segment performance, and updated 2026 financial guidance.
View raw filing on EDGAR →This is a press release announcing Super Group's second quarter 2026 financial results, including revenue of $684 million, profit of $123 million, and Adjusted EBITDA of $204 million. The company also raised full-year 2026 guidance to >$2.6 billion revenue and >$710 million Adjusted EBITDA. The document includes unaudited consolidated financial statements (income statement, balance sheet, and cash flow statement) and is clearly a quarterly earnings disclosure material to investors.
View raw filing on EDGAR →Space Exploration Technologies Corp. issued an earnings release on August 4, 2026, announcing financial results for the quarter ended June 30, 2026. The disclosure includes consolidated statements of operations, segment-level financial data (Space, Connectivity, AI), and detailed business highlights. This is a standard quarterly earnings release disclosing results of operations and financial condition under Item 2.02, with the earnings release furnished as Exhibit 99.1.
View raw filing on EDGAR →Pacira BioSciences issued a press release on August 4, 2026, announcing its second quarter 2026 financial results, including total revenue of $192.4 million (6% YoY growth), GAAP net income of $4.7 million, and non-GAAP net income of $29.5 million. The disclosure includes detailed financial highlights, segment performance, and updated full-year 2026 guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →Digital Turbine issued a press release on August 4, 2026 announcing financial results for the fiscal first quarter ended June 30, 2026. The disclosure includes quarterly revenue of $166.0 million (27% YoY growth), GAAP net loss of $3.2 million, non-GAAP adjusted net income of $24.1 million, and non-GAAP adjusted EBITDA of $42.5 million (69% YoY growth), along with raised full-year fiscal 2027 guidance of $650–$670 million in revenue and $145–$155 million in non-GAAP adjusted EBITDA. This is a standard quarterly earnings release filed under Item 2.02.
View raw filing on EDGAR →BlackLine's board approved an increase to its stock buyback program by $100 million, bringing total authorization to $600 million. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs" per the taxonomy. The $100 million incremental authorization is material to investors assessing capital allocation and shareholder returns.
View raw filing on EDGAR →Tanger Inc. issued a press release on August 4, 2026 announcing its results of operations and financial condition for the quarter ended June 30, 2026, including quarterly net income of $0.29 per share, FFO of $0.64 per share, and year-to-date results, with supplemental operating and financial data and updated 2026 guidance.
View raw filing on EDGAR →